Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 772 Records) |
| Query Trace: Carcinoma and Egfr[original query] |
|---|
| Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection. Cancers 2023 12 15 (23): . Hwa Kyung Park, Yoo Duk Choi, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Joon Young Yoon, Chang-Seok Yoon, Hyung-Joo Oh, Young-Chul Kim, In-Jae |
| Clonality Analysis for the Relationship between the Pulmonary Combined Neuroendocrine Carcinoma and "the So-Called Reported Histologic Transformation". Cancers 2023 12 15 (23): . Haiyue Wang, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Weijing Cai, Dongmei L |
| Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 12 187 107439. Lei Wang, Meng Diao, Zheng Zhang, Minlin Jiang, Shifu Chen, Deping Zhao, Zhenguo Liu, Caicun Zh |
| Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer. JAMA network open 2023 12 6 (12): e2347700. Tomohiro Sakamoto, Taichi Matsubara, Takayuki Takahama, Toshihide Yokoyama, Atsushi Nakamura, Takaaki Tokito, Tatsuro Okamoto, Hiroaki Akamatsu, Masahide Oki, Yuki Sato, Kazunori Tobino, Satoshi Ikeda, Masahide Mori, Chihiro Mimura, Ken Maeno, Satoru Miura, Toshiyuki Harada, Kunihiro Nishimura, Manabu Hiraoka, Hirotsugu Kenmotsu, Junya Fujimoto, Mototsugu Shimokawa, Nobuyuki Yamamoto, Kazuhiko Nakaga |
| Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
| Aumolertinib: effective treatment for asymptomatic pulmonary giant cell carcinoma with EGFR L858R mutation - a case report. Frontiers in oncology 2023 12 13 1279045. Wenxing Yang, Ze Yang, Kaiqiang Wang, Peiquan Zhu, Jiangtao |
| Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521. JCO global oncology 2024 9 10 e2400125. Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho, Kang-Yun Lee, Chin-Fu Hsiao, Fan-Chen Ku, Wei-Tse Fang, James Chih-Hsin Ya |
| An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma. Discover oncology 2024 8 15 (1): 382. Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizusihima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirokazu Taniguchi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Minehiko Inoma |
| Early Diagnostic Markers for Esophageal Squamous Cell Carcinoma: CNA Gene Identification and cfDNA Detection. Laboratory investigation; a journal of technical methods and pathology 2024 8 102127. Jiamin Chen, Xi Liu, Zhihua Zhang, Ruibing Su, Yiqun Geng, Yi Guo, Yimin Zhang, Min |
| Comprehensive Analysis Reveals Epithelial Growth Factor Receptor as a Potential Diagnostic Biomarker in Glioblastoma Multiforme. Cureus 2024 8 16 (7): e64506. Amna Makawi, Somia A Khalafallah, Israa M Faris, Mohamed Alfa |
| The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases. Frontiers in oncology 2024 8 14 1382394. Philippe Metellus, Clara Camilla, Emilie Bialecki, Nathalie Beaufils, Christine Vellutini, Eric Pellegrino, Pascale Tomasini, Manmeet S Ahluwalia, Alireza Mansouri, Isabelle Nanni, L'Houcine Ouaf |
| Comparing the Effectiveness of Afatinib and Osimertinib for Patients With PD-L1-positive EGFR-mutant Non-small Cell Carcinoma. Cancer diagnosis & prognosis 2024 7 4 (4): 515-520. Minehiko Inomata, Yosuke Kawashima, Ryota Saito, Daisuke Morinaga, Hitomi Nogawa, Masamichi Sato, Yohei Suzuki, Satoru Yanagisawa, Takashi Kikuchi, Daisuke Jingu, Naruo Yoshimura, Toshiyuki Harada, Eisaku Miyauc |
| Highly consistency of PIK3CA mutation spectrum between circulating tumor DNA and paired tissue in lung cancer patients. Heliyon 2024 7 10 (13): e34013. Yan Liu, Hui Li, Xiang Li, Tingting Zhang, Yang Zhang, Jing Zhu, Heran Cui, Rixin Li, Ying Che |
| Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation: a retrospective study and pooled analysis. Frontiers in oncology 2024 7 14 1354854. Xueming Xia, Wei Du, Yan Zhang, Yanying Li, Min Yu, Yongmei L |
| A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19). Lung cancer (Amsterdam, Netherlands) 2024 7 194 107870. Yu Jung Kim, Soyeon Kim, Tae Min Kim, Koung Jin Suh, Miso Kim, Se Hyun Kim, Bhumsuk Keam, Dong-Wan Kim, Jong Seok Lee, Dae Seog H |
| Discovery of genomic and transcriptomic pleiotropy between kidney function and soluble receptor for advanced glycation end products using correlated meta-analyses: The Long Life Family Study. Aging cell 2024 6 e14261. Mary F Feitosa, Shiow J Lin, Sandeep Acharya, Bharat Thyagarajan, Mary K Wojczynski, Allison L Kuipers, Alexander Kulminski, Kaare Christensen, Joseph M Zmuda, Michael R Brent, Michael A Provin |
| Prognostic impact of EGFR and CASP8 gene mutations in cutaneous squamous cell carcinoma: a retrospective multistudy analysis. International journal of dermatology 2024 6 . Nilesh Kodali, Abhijit Bhattaru, Shivkar Amara, Robert A Schwar |
| Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features. Molecular diagnosis & therapy 2024 6 . Qiang Wang, Bo Yu, Shuilong Zhang, Dongliang Wang, Zhifu Xiao, Hongjing Meng, Lingxiang Dong, Yuhang Zhang, Jie Wu, Zebin Hou, Yunji Zhu, Dewei |
| The predictive value of serum tumor markers for EGFR mutation in non-small cell lung cancer patients with non-stage IA. Heliyon 2024 5 10 (9): e29605. Wenxing Du, Tong Qiu, Hanqun Liu, Ao Liu, Zhe Wu, Xiao Sun, Yi Qin, Wenhao Su, Zhangfeng Huang, Tianxiang Yun, Wenjie Ji |
| PTPN23[Thr] variant reduces susceptibility and tumorigenesis in esophageal squamous cell carcinoma through dephosphorylation of EGFR. Cancer letters 2024 5 592 216936. Siyuan Niu, Jialing Ma, Yueping Li, Xinying Yue, Ke Shi, Miaoxin Pan, Lina Song, Yuqian Tan, Linglong Gu, Shasha Liu, Jiang Cha |
| NKX2?1 copy number alterations are associated with oncogenic, immunological and prognostic remodeling in non?small cell lung cancer. Oncology letters 2024 5 28 (1): 303. Herdee Gloriane C Luna, Marcelo Severino Imasa, Necy Juat, Katherine V Hernandez, Treah May Sayo, Gloria Cristal-Luna, Sheena Marie Asur-Galang, Mirasol Bellengan, Kent John Duga, Bien Brian Buenaobra, Marvin I De Los Santos, Daniel Medina, Jamirah Samo, Venus Minerva Literal, Sullian Sy-Nav |
| [Advances of Molecular Targeted Therapy in EGFR-mutated Squamous Cell Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2024 5 27 (4): 283-290. Bingwan Xiong, Wenfei Ke, Wenyang Jia |
| Clinicopathological characterization of next-generation sequencing detected mutations in lung cancers-a single-center experience. Translational lung cancer research 2024 5 13 (4): 799-810. Julia Walter, Amanda Tufman, Jörg Kumbrink, Jens Neumann, Kathrin Kahnert, Laura Sellmer, Andreas Jung, Jürgen Behr, Diego Kauffmann-Guerre |
| Case report: Efficacy of icotinib treatment in lung adenocarcinoma with esophageal squamous cell carcinoma: a rare case of double primary malignant tumors. Frontiers in medicine 2024 4 11 1266062. Min Deng, Xiaoqing Li, Honghao Mu, Man Wei, Lan S |
| Frequency of KRAS and BRAF mutations in colorectal carcinoma and their association with clinical-pathological characteristics in a tertiary hospital in Kenya. Frontiers in medicine 2024 10 11 1433120. Samuel Gakinya, Allan Njau, Abdulkarim Abdallah, Ancent Nzioka, James Ogu |
| Expression of Epidermal Growth Factor Receptor (EGFR) and ?-catenin in Colorectal Carcinoma and its Correlation with Tumor Grade and Stage. Indian journal of surgical oncology 2024 1 14 (4): 758-764. Alka Yadav, Sompal Singh, Namrata Sarin, Mukta Pujani, Ruchira Wadhwa, Monica Sarohi, Aiswarya |
| A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma. Journal of translational medicine 2024 1 22 (1): 87. Jie Peng, Dan Zou, Xudong Zhang, Honglian Ma, Lijie Han, Biao Y |
| FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma. Contemporary oncology (Poznan, Poland) 2024 1 27 (3): 211-216. Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stok?o |
| Discovery of genomic and transcriptomic pleiotropy between kidney function and soluble receptor for advanced glycation end-products using correlated meta-analyses: The Long Life Family Study (LLFS). medRxiv : the preprint server for health sciences 2024 1 . Mary F Feitosa, Shiow J Lin, Sandeep Acharya, Bharat Thyagarajan, Mary K Wojczynski, Allison L Kuipers, Alexander Kulminski, Kaare Christensen, Joseph M Zmuda, Michael R Brent, Michael A Provin |
| Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma". Thoracic cancer 2024 1 . Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, Tetsuya Isaka, Kanako Shinada, Emi Yoshioka, Atsuya Narita, Kengo Katakura, Tetsuro Kondo, Terufumi Kato, Takuya Nagashima, Haruhiro Saito, Hiroyuki I |
- Page last reviewed:Feb 1, 2024
- Content source: